Visual Outcome in Ocular Toxoplasmosis: A Case Series of 30 Patients from Ghana

Purpose: To determine visual outcome (low vision and blindness) in patients with inactive ocular toxoplasmosis. Methods: This study employed a cross sectional design involving a series of 30 patients with inactive toxoplasmic ocular lesions. Ophthalmic assessment including best corrected visual acuity (BCVA) measurement, slit lamp biomicroscopy, and dilated fundus examination by indirect ophthalmoscopy was performed on all participants. Ocular toxoplasmosis was diagnosed based on characteristic retinal lesions in addition to a positive serologic testing using commercial ELISA kits. Visual impairment (VI) was determined based on the International Classification of Diseases. Results: Their ages ranged from 16-59 years (mean age of 34.2 ± 14.19), with 19 (63.3%) males and 11 (36.7%) females. There were 33 infected eyes in all (3 patients had bilateral cases). The most common complaint (77%) was blurred vision in the infected eyes. 11 (33%) eyes had mild or no visual impairment (VI category 1), 22 (67%) eyes had low vision (VA<6/18), and 11 (33%) eyes were blind (VA<3/60). Posterior pole (p<0.001) and larger retinal lesions (p=0.04) were the major causes of visual impairment. However, there was no association between visual impairment and the number of lesions occurring in the infected eyes (χ2=3.52, p=0.11). Older patient age was significantly associated with: posterior pole lesions (0.003), larger retinal lesion sizes (p=0.001) and multiple lesions (p=0.001). Only three cases each of strabismus and bilateral involvement suggest that acquired infection is more common in this Ghanaian population. Conclusion: Low vision and blindness were common in Toxoplasma eye infection in our Ghanaian population and that posterior pole and larger retinal lesions rather than multiple lesions were the major causes of reduced vision.

[1]  E. Abu,et al.  Epidemiology of Ocular Toxoplasmosis in Three Community Surveys in the Central Region of Ghana, West Africa , 2016, Ophthalmic epidemiology.

[2]  G. Ghartey-Kwansah,et al.  Infection risk factors associated with seropositivity for Toxoplasma gondii in a population-based study in the Central Region, Ghana , 2014, Epidemiology and Infection.

[3]  M. Petzl-Erler,et al.  Single nucleotide polymorphisms in the interferon gamma gene are associated with distinct types of retinochoroidal scar lesions presumably caused by Toxoplasma gondii infection , 2013, Memorias do Instituto Oswaldo Cruz.

[4]  E. Cunningham,et al.  Prevalence, Clinical Characteristics, and Causes of Vision Loss in Patients with Ocular Toxoplasmosis , 2011, European journal of ophthalmology.

[5]  D. Boamah,et al.  Sero-epidemiology of toxoplasmosis amongst pregnant women in the greater accra region of ghana. , 2010, Ghana medical journal.

[6]  J. Gómez‐Marín,et al.  Incidence and clinical characteristics in a Colombian cohort of ocular toxoplasmosis , 2009, Eye.

[7]  M. Burnier,et al.  Ocular toxoplasmosis: an update and review of the literature. , 2009, Memorias do Instituto Oswaldo Cruz.

[8]  F. Yu,et al.  Intraocular inflammation associated with ocular toxoplasmosis: relationships at initial examination. , 2008, American journal of ophthalmology.

[9]  G. Holland Ocular toxoplasmosis: a global reassessment. Part I: epidemiology and course of disease. , 2003, American journal of ophthalmology.

[10]  D. Kruszon-Moran,et al.  Toxoplasma gondii Infection in the United States, 1999–2000 , 2003, Emerging infectious diseases.

[11]  Suhardjo,et al.  Clinical manifestations of ocular toxoplasmosis in Yogyakarta, Indonesia: a clinical review of 173 cases. , 2003, The Southeast Asian journal of tropical medicine and public health.

[12]  A. Rothova,et al.  Ocular toxoplasmosis: clinical features and prognosis of 154 patients. , 2002, Ophthalmology.

[13]  R. Nussenblatt,et al.  An unusually high prevalence of ocular toxoplasmosis in southern Brazil. , 1992, American journal of ophthalmology.

[14]  M. Marsetio,et al.  Visual impairment and blindness in ocular toxoplasmosis cases. , 1991, The Southeast Asian journal of tropical medicine and public health.

[15]  J. O. Ayanru The problem of uveitis in Bendel State of Nigeria: experience in Benin City. , 1977, The British journal of ophthalmology.

[16]  S. Tabatabaei,et al.  Ocular toxoplasmosis in Iran: 40 cases analysis. , 2011, International journal of ophthalmology.

[17]  P. Ayeh-Kumi,et al.  Sero-prevalence of toxoplasmosis among patients visiting the Korle-Bu Teaching Hospital, Accra, Ghana , 2010 .

[18]  L. Kodjikian,et al.  Ocular manifestations in congenital toxoplasmosis , 2005, Graefe's Archive for Clinical and Experimental Ophthalmology.

[19]  G. Holland Ocular toxoplasmosis: a global reassessment. Part II: disease manifestations and management. , 2004, American journal of ophthalmology.